|
Market Closed -
Euronext Paris
03:55:00 17/11/26 am AEDT
|
After hours 05:37:21 am | |||
| 1.236 EUR | +3.00% |
|
1.231 | -0.40% |
| 14/11 | Stifel reviews Innate Pharma's lead development program | |
| 13/11 | Certain Ordinary Shares of Innate Pharma S.A. are subject to a Lock-Up Agreement Ending on 13-NOV-2026. | CI |
| Market Cap | 112M 124M 104M 93.84M 177M 11.62B 183M 1.25B 495M 6.24B 464M 455M 19.75B | P/E 2026 * |
3.04x | P/E 2027 * | 1.33x |
|---|---|---|---|---|---|
| Enterprise Value | 57.44M 63.23M 53.07M 47.94M 90.47M 5.94B 93.65M 638M 253M 3.19B 237M 232M 10.09B | EV / Sales 2026 * |
1.21x | EV / Sales 2027 * | -0.48x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IPH | Real-time | |
| IPHp | Real-time | ||
| IDD | Delayed | ||
| IPHYF | Delayed | ||
| IDD | Delayed | ||
| IDD | Real-time | ||
| IDD | Delayed | ||
| 0EVI | Delayed | ||
| 0EVI | Real-time | ||
| IDD | Real-time | ||
| 4IPH | End-of-day quote |
Last Transcript: Innate Pharma
| 1 day | +3.00% | ||
| 1 week | -5.36% | ||
| Current month | -1.59% | ||
| 1 month | -5.07% | ||
| 3 months | -31.56% | ||
| 6 months | -36.55% | ||
| Current year | -22.85% |
| 1 week | 1.2 | 1.42 | |
| 1 month | 1.17 | 1.42 | |
| Current year | 1.03 | 2.33 | |
| 1 year | 1.03 | 2.33 | |
| 3 years | 1.03 | 2.8 | |
| 5 years | 1.03 | 4.84 | |
| 10 years | 1.03 | 15.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/11/2024 | |
Frederic Lombard
DFI | Director of Finance/CFO | 51 | 01/04/2021 |
Markus Jensen
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 01/01/2024 | |
| Director/Board Member | 65 | 27/04/2015 | |
Pascale Boissel
BRD | Director/Board Member | 60 | 19/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/8/26 | BPIFrance Participations SA /PRIVATE EQUITY/
| Buy | Company | 1,764,705 | 1.8789% | |
| 20/1/26 | Buy | Executive/Senior Manager | 50,000 | 0.0542% | ||
| 16/1/26 | Buy | Chief Financial Officer | 50,000 | 0.0542% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.00% | -5.36% | -21.07% | -45.67% | 124M | ||
| -1.29% | -1.76% | +51.98% | +64.66% | 66.33B | ||
| -0.09% | +2.79% | +10.75% | +95.02% | 60.62B | ||
| +0.63% | +1.64% | +24.25% | +89.70% | 55.5B | ||
| -0.81% | -0.92% | +9.79% | +118.58% | 47.58B | ||
| -0.27% | -5.06% | +22.49% | +29.26% | 43.69B | ||
| -3.15% | -16.63% | +141.36% | +685.29% | 37.27B | ||
| +0.23% | +1.66% | +14.85% | +49.06% | 36.57B | ||
| +2.35% | -3.61% | +78.64% | +60.70% | 32.22B | ||
| +2.18% | +6.38% | -37.43% | +405.36% | 26.58B | ||
| Average | +0.30% | -0.15% | +29.56% | +155.20% | 41B | |
| Weighted average by Cap. | -0.18% | +0.33% | +35.03% | +152.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.48M 52.26M 43.87M 39.63M 74.78M 4.91B 77.41M 528M 209M 2.63B 196M 192M 8.34B | 89.32M 98.31M 82.52M 74.54M 141M 9.23B 146M 992M 393M 4.95B 369M 361M 15.69B |
| Net income | -859K -946K -794K -717K -1.35M -88.78M -1.4M -9.54M -3.78M -47.64M -3.55M -3.47M -151M | 12.52M 13.78M 11.57M 10.45M 19.72M 1.29B 20.42M 139M 55.14M 695M 51.73M 50.63M 2.2B |
| Net Debt | -55M -60.54M -50.82M -45.9M -86.62M -5.68B -89.67M -611M -242M -3.05B -227M -222M -9.66B | -155M -171M -143M -129M -244M -16.03B -253M -1.72B -683M -8.6B -641M -627M -27.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/11/26 | EUR 1.236 | +3.00% | 478,469 |
| 13/11/26 | EUR 1.200 | -9.50% | 1,072,958 |
| 12/11/26 | EUR 1.326 | -4.33% | 543,667 |
| 11/11/26 | EUR 1.386 | +5.00% | 641,187 |
| 10/11/26 | EUR 1.320 | +1.07% | 153,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPH Stock
Select your edition
All financial news and data tailored to specific country editions

















